The DOI matches its Crossref record; the references it cites are not checked yet.
Acceptance of the Respiratory Syncytial Virus Vaccine in Pregnant Individuals
Abstract
The respiratory syncytial virus (RSV) vaccine was officially offered to pregnant individuals in 2023–2024, with the purpose of providing immunity to infants and young children. We performed a retrospective review to determine the rate of offering the RSV vaccine and acceptance of the vaccine among patients between 32 0/7 and 36 6/7 weeks of gestation. A prospective survey was administered to examine barriers to RSV vaccination. We identified 206 patients, including 111 (53.8%) who were offered the vaccine and 95 (46.1%) who were not offered the vaccine. Of those who were offered the vaccine, 62 (55.9%) accepted and 49 (44.1%) declined. Individuals who declined had significantly higher rates of declining other vaccines in pregnancy (P<.001). More than half of those who declined the RSV vaccine reported both accepting the RSV antibody for their newborn and plans of accepting the vaccine in subsequent pregnancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists haven’t been fetched yet
Cited by 3
Research works printed but not linked: 4
- Hammitt, 2022, Nirsevimab for prevention of RSV in healthy late-preterm and term infants, N Engl J Med, 386, 837, 10.1056/NEJMoa2110275 · DOI
- Kampmann, 2023, Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants, N Engl J Med, 388, 1451, 10.1056/NEJMoa2216480 · DOI · Paper page
- Mitchell, 2023, Vaccine hesitancy in pregnant women: a narrative review, Vaccine, 41, 4220, 10.1016/j.vaccine.2023.05.047 · DOI
- Morales, 2020, The faces of influenza vaccine recommendation: a Literature review of the determinants and barriers to health providers' recommendation of influenza vaccine in pregnancy, Vaccine, 38, 4805, 10.1016/j.vaccine.2020.04.033 · DOI
Metadata
- Authors
- Tucker, T., Garvey, Z., O'Sullivan, D., & Loza, A.
- Venue
- O&G Open
- Published
- 2024-08-08
- Volume
- 1
- Issue
- 3
- Pages
- 026
- ISSN
- 2994-9726
- Cited by
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acceptance of the Respiratory Syncytial Virus Vaccine in Pregnant Individuals. https://app.cochat.ai/papers/10.1097/og9.0000000000000026
- The paper
- Tucker, T., Garvey, Z., O'Sullivan, D., & Loza, A. (2024). Acceptance of the Respiratory Syncytial Virus Vaccine in Pregnant Individuals. O&G Open. https://doi.org/10.1097/og9.0000000000000026
